[go: up one dir, main page]

DK3458460T3 - Imidazoler som histondemethylase-inhibitorer - Google Patents

Imidazoler som histondemethylase-inhibitorer Download PDF

Info

Publication number
DK3458460T3
DK3458460T3 DK17723710.4T DK17723710T DK3458460T3 DK 3458460 T3 DK3458460 T3 DK 3458460T3 DK 17723710 T DK17723710 T DK 17723710T DK 3458460 T3 DK3458460 T3 DK 3458460T3
Authority
DK
Denmark
Prior art keywords
histondemethylase
imidazoles
inhibitors
histondemethylase inhibitors
Prior art date
Application number
DK17723710.4T
Other languages
English (en)
Inventor
Paola Vianello
Alessia Romussi
Anna Cappa
Paolo Trifiro'
Mario Varasi
Luca Sartori
Ciro Mercurio
Original Assignee
Inst Europeo Di Oncologia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Europeo Di Oncologia S R L filed Critical Inst Europeo Di Oncologia S R L
Application granted granted Critical
Publication of DK3458460T3 publication Critical patent/DK3458460T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK17723710.4T 2016-05-18 2017-05-18 Imidazoler som histondemethylase-inhibitorer DK3458460T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16170238.6A EP3246330A1 (en) 2016-05-18 2016-05-18 Imidazoles as histone demethylase inhibitors
PCT/EP2017/062009 WO2017198780A1 (en) 2016-05-18 2017-05-18 Imidazoles as histone demethylase inhibitors

Publications (1)

Publication Number Publication Date
DK3458460T3 true DK3458460T3 (da) 2021-03-01

Family

ID=56014931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17723710.4T DK3458460T3 (da) 2016-05-18 2017-05-18 Imidazoler som histondemethylase-inhibitorer

Country Status (8)

Country Link
US (2) US10562914B2 (da)
EP (2) EP3246330A1 (da)
JP (1) JP6972024B2 (da)
CN (1) CN109641918B (da)
AU (1) AU2017266325B2 (da)
CA (1) CA3063785A1 (da)
DK (1) DK3458460T3 (da)
WO (1) WO2017198780A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3246330A1 (en) 2016-05-18 2017-11-22 Istituto Europeo di Oncologia S.r.l. Imidazoles as histone demethylase inhibitors
DK3661510T3 (da) 2017-08-03 2025-01-02 Oryzon Genomics Sa Fremgangsmåder til behandling af adfærdsændringer
CN113631164A (zh) 2019-03-20 2021-11-09 奥莱松基因组股份有限公司 使用kdm1a抑制剂如化合物伐菲德司他治疗注意缺陷多动症的方法
SG11202109159VA (en) 2019-03-20 2021-10-28 Oryzon Genomics Sa Methods of treating borderline personality disorder
JP2022546908A (ja) 2019-07-05 2022-11-10 オリゾン・ゲノミクス・ソシエダッド・アノニマ Kdm1a阻害剤を使用した小細胞肺がんの個別化された処置のためのバイオマーカーおよび方法
IT202000007873A1 (it) 2020-04-14 2021-10-14 St Europeo Di Oncologia S R L Molecole per uso nel trattamento delle infezioni virali
WO2022058405A2 (en) 2020-09-16 2022-03-24 Ifom - Istituto Firc Di Oncologia Molecolare Histone deacetylase inhibitors and uses thereof
MX2023011779A (es) 2021-04-08 2023-11-22 Oryzon Genomics Sa Combinaciones de inhibidores de lsd1 para el tratamiento de canceres mieloides.
EP4522137A1 (en) 2022-05-09 2025-03-19 Oryzon Genomics, S.A. Methods of treating nf1-mutant tumors using lsd1 inhibitors
CN119546292A (zh) 2022-05-09 2025-02-28 奥莱松基因组股份有限公司 使用lsd1抑制剂治疗恶性周围神经鞘瘤(mpnst)的方法
WO2024110649A1 (en) 2022-11-24 2024-05-30 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors and menin inhibitors for treating cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204018A (en) 1990-02-01 1993-04-20 Hoffmann-La Roche Inc. Liquid crystals
GB0321003D0 (en) * 2003-09-09 2003-10-08 Angeletti P Ist Richerche Bio Compounds, compositions and uses
CA2594665A1 (en) 2005-01-19 2006-07-27 Biolipox Ab Thienopyrroles useful in the treatment of inflammation
US20090247766A1 (en) * 2008-03-27 2009-10-01 University Of Southern California Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof
US8389580B2 (en) 2009-06-02 2013-03-05 Duke University Arylcyclopropylamines and methods of use
CN102985402B (zh) 2010-04-20 2015-04-29 罗马大学 反苯环丙胺衍生物作为组蛋白去甲基酶lsd1和/或lsd2的抑制剂
US9061966B2 (en) 2010-10-08 2015-06-23 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
GB201017345D0 (en) 2010-10-14 2010-11-24 Proximagen Ltd Receptor antagonists
US9067949B2 (en) 2011-01-19 2015-06-30 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
CN103842332B (zh) 2011-08-09 2016-08-17 武田药品工业株式会社 环丙胺化合物
ES2821548T3 (es) 2011-08-15 2021-04-26 Univ Utah Res Found Análogos de (E)-N'-(1-feniletiliden) benzohidrazida sustituida como inhibidores de desmetilasas de histonas
EP2740474A1 (en) 2012-12-05 2014-06-11 Instituto Europeo di Oncologia S.r.l. Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
WO2014164867A1 (en) * 2013-03-11 2014-10-09 Imago Biosciences Kdm1a inhibitors for the treatment of disease
EP2969007B1 (en) 2013-03-14 2019-05-08 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US10005769B2 (en) 2013-06-18 2018-06-26 4Sc Ag 2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors
CN104278008B (zh) * 2013-07-12 2020-08-21 北京宏冠再生医学科技有限公司 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
EP2993175A1 (en) 2014-09-05 2016-03-09 IEO - Istituto Europeo di Oncologia Srl Thienopyrroles as histone demethylase inhibitors
EP3246330A1 (en) 2016-05-18 2017-11-22 Istituto Europeo di Oncologia S.r.l. Imidazoles as histone demethylase inhibitors

Also Published As

Publication number Publication date
AU2017266325B2 (en) 2021-07-08
US10562914B2 (en) 2020-02-18
EP3458460A1 (en) 2019-03-27
JP6972024B2 (ja) 2021-11-24
CN109641918B (zh) 2021-12-21
US20190152987A1 (en) 2019-05-23
CN109641918A (zh) 2019-04-16
WO2017198780A1 (en) 2017-11-23
EP3458460B1 (en) 2020-12-09
US10961255B2 (en) 2021-03-30
CA3063785A1 (en) 2017-11-23
EP3246330A1 (en) 2017-11-22
AU2017266325A1 (en) 2019-01-17
US20200299303A1 (en) 2020-09-24
JP2019519520A (ja) 2019-07-11

Similar Documents

Publication Publication Date Title
IL269196A (en) Novel inhibitors
LT3468966T (lt) Menino-mll sąveikos inhibitoriai
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
LT3303334T (lt) Tirozinkinazės inhibitoriai
DK3442972T3 (da) Bromdomænehæmmere
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
HUE042335T2 (hu) ROR-gamma dihidropirrolopiridin inhibitorai
DK3105218T3 (da) Cyclopropylaminer som lsd1-inhibitorer
DK3105226T3 (da) Cyclopropylaminer som lsd1-inhibitorer
LT3137169T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
DK3271349T3 (da) Benzimidazolederivater som bromodomain-inhibitorer
DK3286183T3 (da) Isoxazolylsubstituerede benzimidazoler
EP3313828A4 (en) METALLO-BETA-Lactamase INHIBITORS
DK3458460T3 (da) Imidazoler som histondemethylase-inhibitorer
HUE050564T2 (hu) Lizinspecifikus demetiláz-1 inhibitorai
HUE058852T2 (hu) Lizinspecifikus demetiláz-1 inhibitorai
DK3571192T3 (da) Jak1-selektive inhibitorer
DK3538528T3 (da) Pyrrolamider som alpha v-integrinhæmmere
DK3288944T3 (da) Imidazopyrazinoner som pde1-inhibitorer
DK3341379T3 (da) EZH2-hæmmere
DK3186242T3 (da) Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
DK3630744T3 (da) Pyrazol-magl-inhibitorer
MA43367A (fr) Inhibiteurs de métallo-bêta-lactamases
DK3114120T3 (da) Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere